Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

#Cannabisstocks: Cannassure Therapeutics (TASE: CSURE) Announces Strategic Partnership With Cannika Holdings

Cannassure signs a binding MOU with Cannika Holdings, expanding their footprint in medical cannabis innovation and R&D


ASHDOD, Israel - January 30, 2019 ( Newswire) Cannassure Therapeutics (TASE: CSURE) announces its collaboration with Cannika Holdings, an agritech incubator specializing in cannabis innovation. Cannika will operate out of the Cannassure campus, utilizing their many facilities that are designed to meet the highest regulatory standards. Start-ups joining the incubator will benefit from an extensive research platform and a community of scientists, researchers, and business professionals. Cannika will provide medical cannabis start-ups with a complete R&D ecosystem that provides scientific financial and business expertise to advance cannabis related initiatives from concept to commercialization.

Nir Peles, Interim Chairman of Cannassure, commented: "We are delighted about this collaboration with Cannika. We are committed to medical cannabis innovation for the purpose of enhancing treatment and improving the quality of life of people worldwide with medical cannabis products. Having a cannabis technological incubator on our campus is directly in line with our strategy, activity and goals. Cannika's leadership team has extensive knowledge and experience in the fields of agritech, science, and business development which gives them the ability to support early stage, cannabis initiatives and fast track their path to successful commercialization."

Hadar Less, Cannika CEO stated, "We are thrilled to partner with Cannassure, a company devoted to R&D and innovation. Cannassure has all the necessary permits and facilities to harbor cannabis innovation. They are building a regulatory compliant state-of-the-art indoor grow facility and extraction and manufacturing facility in addition to their fully operational, scientifically advanced laboratory. Partnering with Cannassure facilitates Cannika's goal of establishing an independent fully licensed R&D facility and enables start-up companies and entrepreneurs to develop and bring technology innovation to the medical cannabis field."

About Cannassure Ltd

Cannassure Therapeutics Ltd. is a subsidiary of Solbar Food Technologies Ltd., a 57 year-old producer of plant based raw materials and solutions for the food and food additives industries. Cannassure holds all the approvals required for establishing a vertically integrated medical cannabis operation and is working in all these areas from breeding, cultivation, extraction, storage, packaging and distribution.


About Cannika Holdings

Cannika funds, cultivates, and commercializes technologies for the cannabis industry. A unique R&D platform that includes a licensed grow area, labs, access to an expertise network, and other resources provides a complete ecosystem to early stage companies and initiatives. Cannika is headquartered in Israel, the beating heart of scientific and technology innovation in this field. Led by a well-rounded team of experienced business, financial, and scientific experts, Cannika is focused on advancing the evolution of the cannabis industry.


For press inquiries contact:

Ran Amir, CEO Cannassure

Marijuana / Hemp / Cannabis Stocks at and

Investorideas Potcasts is on Facebook  Follow Investorideas Potcasts on Twitter  Investorideas Potcasts is on Instagram  Investorideas Potcasts is on LinkedIn Group potcasts - Listen Daily to Investor Ideas Potcasts #Cannabis News and Stocks on the Move

Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks

Follow Pot stocks news - Get News Alerts on Marijuana Stocks Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Learn more about publishing your news release on the newswire

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

Please read privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.